Moreover, bypassing the bloodbrain barrier altogether by direct intrathecal administration of the B cell-depleting agent rituximab was also ineffective in progressive MS (Komori et al., 2016
L.ShawL
Esta revisin sintetiza los avances ms recientes en la etiopatogenia del vitligo, ofreciendo una visin completa de los mecanismos implicados, y abriendo nuevas posibilidades para el desarrollo de enfoques teraputicos basados en este conocimiento
Diese Interaktion mit SIRT1, einem Schluesselenzym der zellularen Stressantwort und Langlebigkeit, eroeffnet neue Forschungsrichtungen
In the late stages, however, increased energy need is correlated with an increase in ROS production [37]
No human approval: there are no official human guidelines, because the compound is unapproved